SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-10-30 |
| Reported value | $53,189,191 |
| Positions | 2 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| STOKE THERAPEUTICS INC | STOK | COM | $53,020,254 | 2,256,181 |
| SPDR SER TR | XBI | S&P BIOTECH | $168,937 | 1,686 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.